(Q36027025)

11 August 2017

0 references

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium (English)

1 reference

Australian Ovarian Cancer Study Group

11 August 2017

0 references

1 reference

10

Australian Ovarian Cancer Study Group

1 reference

11 August 2017

A Jensen

3

0 references

Estrid Høgdall

E Høgdall

47

0 references

Keitaro Matsuo

K Matsuo

29

0 references

Diether Lambrechts

13

D Lambrechts

1 reference

11 August 2017

55

A Ziogas

1 reference

11 August 2017

43

N Wentzensen

1 reference

11 August 2017

45

L A Brinton

1 reference

11 August 2017

11

P A Fasching

1 reference

11 August 2017

21

J Chang-Claude

1 reference

11 August 2017

12

M W Beckmann

1 reference

11 August 2017

40

E V Bandera

1 reference

11 August 2017

54

H Anton-Culver

1 reference

11 August 2017

46

J Lissowska

1 reference

11 August 2017

6

A deFazio

1 reference

11 August 2017

14

I Vergote

1 reference

11 August 2017

56

C L Pearce

1 reference

11 August 2017

24

K Moysich

1 reference

11 August 2017

39

K L Terry

1 reference

11 August 2017

34

B L Fridley

1 reference

11 August 2017

31

E L Goode

1 reference

11 August 2017

20

K G Wicklund

1 reference

11 August 2017

19

J A Doherty

1 reference

11 August 2017

35

C Høgdall

1 reference

Ovarian Cancer Association Consortium

11 August 2017

59

Ovarian Cancer Association Consortium

1 reference

11 August 2017

22

M T Goodman

1 reference

11 August 2017

C M Nagle

1

1 reference

11 August 2017

S C Dixon

2

1 reference

11 August 2017

S K Kjaer

4

1 reference

11 August 2017

F Modugno

5

1 reference

11 August 2017

S Fereday

7

1 reference

11 August 2017

J Hung

8

1 reference

11 August 2017

S E Johnatty

9

1 reference

11 August 2017

E Van Nieuwenhuysen

15

1 reference

11 August 2017

S Lambrechts

16

1 reference

11 August 2017

H A Risch

17

1 reference

11 August 2017

M A Rossing

18

1 reference

11 August 2017

R B Ness

23

1 reference

11 August 2017

F Heitz

25

1 reference

11 August 2017

A du Bois

26

1 reference

11 August 2017

P Harter

27

1 reference

11 August 2017

I Schwaab

28

1 reference

11 August 2017

S Hosono

30

1 reference

11 August 2017

R A Vierkant

32

1 reference

11 August 2017

M C Larson

33

1 reference

11 August 2017

J M Schildkraut

36

1 reference

11 August 2017

R P Weber

37

1 reference

11 August 2017

D W Cramer

38

1 reference

11 August 2017

L Paddock

41

1 reference

11 August 2017

L Rodriguez-Rodriguez

42

1 reference

11 August 2017

H P Yang

44

1 reference

11 August 2017

L Lundvall

48

1 reference

11 August 2017

A Whittemore

49

1 reference

11 August 2017

V McGuire

50

1 reference

11 August 2017

W Sieh

51

1 reference

11 August 2017

J Rothstein

52

1 reference

11 August 2017

R Sutphen

53

1 reference

11 August 2017

A H Wu

57

1 reference

11 August 2017

P M Webb

58

1 reference

11 August 2017

language of work or name

English

0 references

publication date

7 July 2015

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

113

1 reference

11 August 2017

5

1 reference

11 August 2017

817-826

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

11 August 2017

start time

7 July 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/bjc.2015.245

0 references

cites work

Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Sun exposure and risk of epithelial ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Hormone response in ovarian cancer: time to reconsider as a clinical target?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Total and individual antioxidant intake and risk of epithelial ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Obesity and ovarian cancer survival: a systematic review and meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Obesity in cancer survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Molecular mechanisms of cancer development in obesity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Assessment of hepatocyte growth factor in ovarian cancer mortality

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

2 October 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Healthy eating index and ovarian cancer risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Inherited determinants of ovarian cancer survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Markers of inflammation and risk of ovarian cancer in Los Angeles County

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Consortium analysis of 7 candidate SNPs for ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Genetic variation in the one-carbon transfer pathway and ovarian cancer risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Improved survival in BRCA2 carriers with ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Adiponectin and cancer: a systematic review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

The impact of obesity on the incidence and treatment of gynecologic cancers: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Survival analysis part I: basic concepts and first analyses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Meta-analysis in clinical trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Obesity-associated adipokines correlate with survival in epithelial ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Menopausal hormone therapy and risk of epithelial ovarian cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

PGR +331 A/G and increased risk of epithelial ovarian cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Effect of obesity on survival in epithelial ovarian cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II)

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Low-dose oral contraceptives: protective effect on ovarian cancer risk

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559823

Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2015.245

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2015.245

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2015.245

A note on quantifying follow-up in studies of failure time

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26151456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26151456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26151456

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2015.245

1 reference

11 August 2017

1 reference

11 August 2017

1 reference